Funded Health Care Startups in Switzerland
Across the 50 most recent health care funding rounds listed for Switzerland, the largest disclosed amount is SkyCell’s $59M closed on 2024-06-25.
Across the 50 most recent health care funding rounds listed for Switzerland, the largest disclosed amount is SkyCell’s $59M closed on 2024-06-25. That figure sits far above the rest: aside from SkyCell, only Neo Medical ($69M on 2024-09-17) breaks the $50M range, and the next-largest disclosed rounds cluster in the teens to low-$20Ms (for example Hedera Dx at $17M on 2025-05-27 and spineart at $23M on 2024-03-18). On stage visibility, Series Unknown is frequent: 18 of 50 rows show “Series Unknown,” and 4 additional rounds are explicitly “undisclosed,” limiting comparability across time.
Geographically, Zurich is the most repeated city label, appearing across multiple entries (e.g., Positrigo and Resmonics both in Zürich on 2025-06-10 and 2025-01-16; Simulands in Zürich on 2023-03-02), while Geneva also recurs (e.g., Multiwave Technologies on 2025-10-04; EBAMed on 2025-01-21). Temporally, rounds span 2022-06-16 (Pipra) through 2025-10-04 (Multiwave Technologies), with a dense set in mid-2024 (June–September 2024 includes SkyCell 2024-06-25, Neo Medical 2024-09-17, and Novostia 2024-09-09).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out as the biggest disclosed round, and how far ahead is it of the next-largest disclosed amounts?
Neo Medical’s $69M (2024-09-17) is the top disclosed amount. Only SkyCell’s $59M (2024-06-25) is also above $50M; most other disclosed rounds are notably lower, including $23M for spineart (2024-03-18) and $17M for Hedera Dx (2025-05-27).
How much of the list has ambiguous or missing round sizes/stage labels (Series Unknown vs undisclosed)?
Stage and amount visibility is limited: 18 of 50 rows are labeled “Series Unknown,” and 4 of 50 rounds are explicitly “undisclosed” for the amount. Examples include Oryl Photonics on 2025-09-09 ($undisclosed) and CARE on 2023-11-01 (Series Seed with amount undisclosed).
Are there clear geographic concentrations across the 50 rows?
Yes. Zürich/Zürich appears repeatedly (e.g., Positrigo on 2025-06-10, Resmonics on 2025-01-16, Simulands on 2023-03-02, Piomic on 2022-07-28), while Geneva also recurs (e.g., Multiwave Technologies 2025-10-04, EBAMed 2025-01-21, Terapet 2024-03-06). This suggests clustering around major Swiss metros rather than a uniform spread.
Which time window looks most active, based on multiple large or frequent closures in a narrow span?
Mid-2024 is dense, with several notable disclosed rounds in sequence: SkyCell ($59M, 2024-06-25), Vanarix ($4M, 2024-07-10), and then a back-to-back cluster in September 2024 including Novostia ($7M, 2024-09-09) and Neo Medical ($69M, 2024-09-17). The date range also extends from 2022-06-16 (Pipra) to 2025-10-04 (Multiwave Technologies).
Which stages appear frequently enough to drive the overall mix, and do the biggest rounds align with them?
Seed and Series A both recur, but “Series Unknown” is the largest single label (18 of 50). The two biggest disclosed rounds—Neo Medical ($69M on 2024-09-17, Series B) and SkyCell ($59M on 2024-06-25, Series D)—occur outside Series A, indicating that larger disclosed financings can land in later-stage labels even when stage classification is often missing.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.